Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | 2.40% | 70.55 | 5.6% | $182.80m | |
| CTLT | Catalent, Inc. | 2.88% | 97.38 | 2.1% | $122.62m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 1.93% | 19.54 | 14.1% | $114.98m | |
| BHC | Bausch Health Cos., Inc. | 1.93% | 19.54 | 0.0% | $82.27m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.02% | 143.28 | 2.4% | $79.60m | |
| GWPH | GW Pharmaceuticals Plc | 1.65% | 129.71 | 6.1% | $68.89m | |
| PRGO | Perrigo Co. Plc | 0.21% | 48.03 | 6.8% | $56.45m | |
| UTHR | United Therapeutics Corp. | 0.35% | 135.54 | 14.1% | $55.32m | |
| SAGE | SAGE Therapeutics, Inc. | -8.62% | 75.57 | 8.6% | $53.25m | |
| ARGX | argenx SE | 6.07% | 281.59 | 0.0% | $40.59m | |
| SAVA | Cassava Sciences, Inc. | 0.78% | 7.76 | 0.0% | $38.85m | |
| ICLR | ICON plc | 1.54% | 191.14 | 4.2% | $36.74m | |
| AMRN | Amarin Corp. Plc | 0.00% | 4.60 | 1.5% | $36.00m | |
| BLRX | BioLineRx Ltd. | 3.11% | 2.32 | 1.8% | $35.68m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -0.32% | 37.27 | 16.8% | $32.30m |
Company Profile
Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: U.S. Branded-Specialty & Established Pharmaceuticals, U.S. Branded-Sterile Injectables, U.S. Generic Pharmaceuticals and International Pharmaceuticals. The U.S. Branded-Specialty & Established Pharmaceuticals segment offers prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics. The U.S. Branded-Sterile Injectables segment consists primarily of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The U.S. Generic Pharmaceuticals segment consists of a differentiated product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays and includes products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health and cardiovascular disease markets, among others. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. The company was founded in 1997 and is headquartered Dublin, Ireland.